Class IOngoingD-0626-2024
Drug recall · August 14, 2024
Umary Acido Hialuronico recall
Why: Marketed without Approved NDA/ANDA. FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.
- Lots / codes
All lots within expiry
- Quantity
- 57, 340 bottles
- Company
- Main Products Inc, Chula Vista, CA
- Distribution
- Nationwide within the U.S
- Initiated
- July 18, 2024 · Voluntary: Firm initiated
- Classified
- August 5, 2024
- Reported
- August 14, 2024
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.